PDB Short entry for 2YK9
HEADER    CHAPERONE                               26-MAY-11   2YK9              
TITLE     TRICYCLIC SERIES OF HSP90 INHIBITORS                                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA;                           
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: N-DOMAIN, RESIDUES 18-223;                                 
COMPND   5 SYNONYM: HEAT SHOCK 86 KDA, HSP 86, HSP86, RENAL CARCINOMA ANTIGEN   
COMPND   6  NY-REN-38, HSP90;                                                   
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 469008;                                     
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)                                  
KEYWDS    CHAPERONE, INHIBITION                                                 
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    A.DUPUY,F.VALLEE                                                      
REVDAT   2   02-NOV-11 2YK9    1       JRNL                                     
REVDAT   1   26-OCT-11 2YK9    0                                                
JRNL        AUTH   F.VALLEE,C.CARREZ,F.PILORGE,A.DUPUY,A.PARENT,L.BERTIN,       
JRNL        AUTH 2 F.THOMPSON,P.FERRARI,F.FASSY,A.LAMBERTON,A.THOMAS,           
JRNL        AUTH 3 R.ARREBOLA,S.GUERIF,A.ROHAUT,V.CERTAL,J.M.RUXER,C.DELORME,   
JRNL        AUTH 4 A.JOUANEN,J.DUMAS,C.GREPIN,C.COMBEAU,H.GOULAOUIC,N.DEREU,    
JRNL        AUTH 5 V.MIKOL,P.MAILLIET,H.MINOUX                                  
JRNL        TITL   TRICYCLIC SERIES OF HEAT SHOCK PROTEIN 90 (HSP90)            
JRNL        TITL 2 INHIBITORS PART I: DISCOVERY OF TRICYCLIC                    
JRNL        TITL 3 IMIDAZO[4,5-C]PYRIDINES AS POTENT INHIBITORS OF THE HSP90    
JRNL        TITL 4 MOLECULAR CHAPERONE.                                         
JRNL        REF    J.MED.CHEM.                   V.  54  7206 2011              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   21972823                                                     
JRNL        DOI    10.1021/JM200784M                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.32 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : BUSTER 2.9.7                                         
REMARK   3   AUTHORS     : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,              
REMARK   3               : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK,              
REMARK   3               : MATTHEWS,TEN EYCK,TRONRUD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.32                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 19.33                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.0                            
REMARK   3   COMPLETENESS FOR RANGE        (%) : 95.82                          
REMARK   3   NUMBER OF REFLECTIONS             : 67186                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD           : THROUGHOUT                     
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3   R VALUE     (WORKING + TEST SET)  : 0.1860                         
REMARK   3   R VALUE            (WORKING SET)  : 0.1855                         
REMARK   3   FREE R VALUE                      : 0.1953                         
REMARK   3   FREE R VALUE TEST SET SIZE   (%)  : 5.05                           
REMARK   3   FREE R VALUE TEST SET COUNT       : 3392                           
REMARK   3   ESTIMATED ERROR OF FREE R VALUE   : NULL                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED               : 20                       
REMARK   3   BIN RESOLUTION RANGE HIGH   (ANGSTROMS) : 1.32                     
REMARK   3   BIN RESOLUTION RANGE LOW    (ANGSTROMS) : 1.35                     
REMARK   3   BIN COMPLETENESS (WORKING+TEST)     (%) : 95.82                    
REMARK   3   REFLECTIONS IN BIN (WORKING + TEST SET) : 3704                     
REMARK   3   BIN R VALUE        (WORKING + TEST SET) : 0.2051                   
REMARK   3   REFLECTIONS IN BIN        (WORKING SET) : 3546                     
REMARK   3   BIN R VALUE               (WORKING SET) : 0.2045                   
REMARK   3   BIN FREE R VALUE                        : 0.2199                   
REMARK   3   BIN FREE R VALUE TEST SET SIZE      (%) : 4.27                     
REMARK   3   BIN FREE R VALUE TEST SET COUNT         : 158                      
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE     : NULL                     
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 1628                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 23                                      
REMARK   3   SOLVENT ATOMS            : 314                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 12.05                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 16.16                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.2860                                               
REMARK   3    B22 (A**2) : -0.3255                                              
REMARK   3    B33 (A**2) : -0.9605                                              
REMARK   3    B12 (A**2) : 0.0000                                               
REMARK   3    B13 (A**2) : 0.0000                                               
REMARK   3    B23 (A**2) : 0.0000                                               
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT                    (A) : 0.136               
REMARK   3   DPI (BLOW EQ-10) BASED ON R VALUE        (A) : 0.048               
REMARK   3   DPI (BLOW EQ-9) BASED ON FREE R VALUE    (A) : 0.047               
REMARK   3   DPI (CRUICKSHANK) BASED ON R VALUE       (A) : 0.045               
REMARK   3   DPI (CRUICKSHANK) BASED ON FREE R VALUE  (A) : 0.045               
REMARK   3                                                                      
REMARK   3   REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797                
REMARK   3               CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601     
REMARK   3                                                                      
REMARK   3  CORRELATION COEFFICIENTS.                                           
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.9446                        
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.9409                        
REMARK   3                                                                      
REMARK   3   NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15                    
REMARK   3   TERM                          COUNT    WEIGHT   FUNCTION.          
REMARK   3    BOND LENGTHS              : 1681   ; 2.00   ; HARMONIC            
REMARK   3    BOND ANGLES               : 2270   ; 2.00   ; HARMONIC            
REMARK   3    TORSION ANGLES            : 596    ; 2.00   ; SINUSOIDAL          
REMARK   3    TRIGONAL CARBON PLANES    : 46     ; 2.00   ; HARMONIC            
REMARK   3    GENERAL PLANES            : 272    ; 5.00   ; HARMONIC            
REMARK   3    ISOTROPIC THERMAL FACTORS : 1681   ; 20.00  ; HARMONIC            
REMARK   3    BAD NON-BONDED CONTACTS   : NULL   ; NULL   ; NULL                
REMARK   3    IMPROPER TORSIONS         : NULL   ; NULL   ; NULL                
REMARK   3    PSEUDOROTATION ANGLES     : NULL   ; NULL   ; NULL                
REMARK   3    CHIRAL IMPROPER TORSION   : 229    ; 5.00   ; SEMIHARMONIC        
REMARK   3    SUM OF OCCUPANCIES        : NULL   ; NULL   ; NULL                
REMARK   3    UTILITY DISTANCES         : NULL   ; NULL   ; NULL                
REMARK   3    UTILITY ANGLES            : NULL   ; NULL   ; NULL                
REMARK   3    UTILITY TORSION           : NULL   ; NULL   ; NULL                
REMARK   3    IDEAL-DIST CONTACT TERM   : 2305   ; 4.00   ; SEMIHARMONIC        
REMARK   3                                                                      
REMARK   3   RMS DEVIATIONS FROM IDEAL VALUES.                                  
REMARK   3    BOND LENGTHS                       (A) : 0.010                    
REMARK   3    BOND ANGLES                  (DEGREES) : 1.10                     
REMARK   3    PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.83                     
REMARK   3    OTHER TORSION ANGLES         (DEGREES) : 14.13                    
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: REFINEMENT NOTE 1: IDEAL-DIST CONTACT     
REMARK   3  TERM CONTACT SETUP. ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY.     
REMARK   4                                                                      
REMARK   4 2YK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAY-11.                  
REMARK 100 THE PDBE ID CODE IS EBI-48443.                                       
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 31-OCT-03                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID14-1                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.934                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD (QUANTUM 210)                  
REMARK 200  DETECTOR MANUFACTURER          : ADSC                               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : PROCESS                            
REMARK 200  DATA SCALING SOFTWARE          : XDS                                
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 67326                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.32                               
REMARK 200  RESOLUTION RANGE LOW       (A) : 45.34                              
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 2.0                                
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.9                               
REMARK 200  DATA REDUNDANCY                : 3.8                                
REMARK 200  R MERGE                    (I) : 0.04                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.39                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 77.0                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.7                                
REMARK 200  R MERGE FOR SHELL          (I) : 0.28                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NONE                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS  (%): 54.13                                      
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z                                                 
REMARK 290       3555   -X,Y,-Z                                                 
REMARK 290       4555   X,-Y,-Z                                                 
REMARK 290       5555   X+1/2,Y+1/2,Z+1/2                                       
REMARK 290       6555   -X+1/2,-Y+1/2,Z+1/2                                     
REMARK 290       7555   -X+1/2,Y+1/2,-Z+1/2                                     
REMARK 290       8555   X+1/2,-Y+1/2,-Z+1/2                                     
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000       33.21450            
REMARK 290   SMTRY2   5  0.000000  1.000000  0.000000       45.34300            
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000       49.36700            
REMARK 290   SMTRY1   6 -1.000000  0.000000  0.000000       33.21450            
REMARK 290   SMTRY2   6  0.000000 -1.000000  0.000000       45.34300            
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       49.36700            
REMARK 290   SMTRY1   7 -1.000000  0.000000  0.000000       33.21450            
REMARK 290   SMTRY2   7  0.000000  1.000000  0.000000       45.34300            
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000       49.36700            
REMARK 290   SMTRY1   8  1.000000  0.000000  0.000000       33.21450            
REMARK 290   SMTRY2   8  0.000000 -1.000000  0.000000       45.34300            
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000       49.36700            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH A2053   LIES ON A SPECIAL POSITION.                         
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     GLY A    15                                                      
REMARK 465     HIS A    16                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   CG2  ILE A    26     O    HOH A  2032              1.79            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    GLY A 167   C   -  N   -  CA  ANGL. DEV. = -19.5 DEGREES          
REMARK 500    HIS A 210   CB  -  CG  -  ND1 ANGL. DEV. =   8.2 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A 105      -60.92   -102.45                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YK9 A1224                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2YI0   RELATED DB: PDB                                   
REMARK 900  STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED-             
REMARK 900  2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90                        
REMARK 900  INHIBITORS.                                                         
REMARK 900 RELATED ID: 2BSM   RELATED DB: PDB                                   
REMARK 900  NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR            
REMARK 900   CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED                 
REMARK 900  DESIGN                                                              
REMARK 900 RELATED ID: 1OSF   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N-                   
REMARK 900  DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN                                
REMARK 900 RELATED ID: 2WI3   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2YE4   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2YI5   RELATED DB: PDB                                   
REMARK 900  STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED-             
REMARK 900  2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90                        
REMARK 900  INHIBITORS.                                                         
REMARK 900 RELATED ID: 2YE5   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2BZ5   RELATED DB: PDB                                   
REMARK 900  STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90                   
REMARK 900  INHIBITORS                                                          
REMARK 900 RELATED ID: 2YEI   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2CCS   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-                   
REMARK 900  PYRAZOL-3-YL)-BENZENE-1,2-DIOL                                      
REMARK 900 RELATED ID: 2YEG   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 1UYF   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-                           
REMARK 900  TRIMETHOXY-BENZYL)-2-FLUORO-9-PENT-4-YLNYL-9H-PURIN                 
REMARK 900  -6-YLAMINE                                                          
REMARK 900 RELATED ID: 1UYI   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-                  
REMARK 900  FLUORO-9-PENT-9H-PURIN-6-YLAMINE                                    
REMARK 900 RELATED ID: 1YC3   RELATED DB: PDB                                   
REMARK 900  CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED                     
REMARK 900  WITHDIHYDROXYPHENYLPYRAZOLES                                        
REMARK 900 RELATED ID: 2YE3   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2BYI   RELATED DB: PDB                                   
REMARK 900  3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-                        
REMARK 900  CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR                   
REMARK 900  CHAPERONE                                                           
REMARK 900 RELATED ID: 2YI6   RELATED DB: PDB                                   
REMARK 900  STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED-             
REMARK 900  2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90                        
REMARK 900  INHIBITORS.                                                         
REMARK 900 RELATED ID: 2VCI   RELATED DB: PDB                                   
REMARK 900  4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS:                    
REMARK 900  POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER            
REMARK 900 RELATED ID: 2WI1   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2XJX   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 2XDK   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND              
REMARK 900 RELATED ID: 2FWZ   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT                  
REMARK 900  WATERSOLUBLE INHIBITOR PU-H71                                       
REMARK 900 RELATED ID: 1UYH   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-                    
REMARK 900  BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE                                 
REMARK 900 RELATED ID: 2XJG   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 2FWY   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT                  
REMARK 900  WATERSOLUBLE INHIBITOR PU-H64                                       
REMARK 900 RELATED ID: 1UYE   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-                           
REMARK 900  TRIMETHOXY-BENZYL)-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE                
REMARK 900 RELATED ID: 1UYL   RELATED DB: PDB                                   
REMARK 900  STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE-BASED INHIBITOR          
REMARK 900   BINDING TO HSP90 ISOFORMS                                          
REMARK 900 RELATED ID: 2XAB   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HSP90 WITH AN INHIBITOR BOUND                          
REMARK 900 RELATED ID: 2YEH   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2XHT   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 1UY7   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4-METHOXY-BENZYL                  
REMARK 900  )-9H-PURIN-6-YLAMINE                                                
REMARK 900 RELATED ID: 2XHR   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND              
REMARK 900 RELATED ID: 2YEF   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2BYH   RELATED DB: PDB                                   
REMARK 900  3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-                        
REMARK 900  CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR                   
REMARK 900  CHAPERONE                                                           
REMARK 900 RELATED ID: 2WI5   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2CDD   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 WITH 4-(4-(2,3-DIHYDRO-BENZOL(1,4)                      
REMARK 900  DIOXIN-6-YL)-5-METHYL-1H-PYRAZOL-3-YL)-6-ETHYL-                     
REMARK 900  BENZENE-1,3-DIOL                                                    
REMARK 900 RELATED ID: 1UY9   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-                       
REMARK 900  YLMETHYL-9-BUTYL-9H-PURIN-6-YLAMINE                                 
REMARK 900 RELATED ID: 1YES   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN"                     
REMARK 900  CONFORMATION                                                        
REMARK 900 RELATED ID: 1BYQ   RELATED DB: PDB                                   
REMARK 900  HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG                             
REMARK 900 RELATED ID: 2YI7   RELATED DB: PDB                                   
REMARK 900  STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED-             
REMARK 900  2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90                        
REMARK 900  INHIBITORS.                                                         
REMARK 900 RELATED ID: 1UY8   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3-TRIMETHOXY-                     
REMARK 900  BENZYL)-9H-PURIN-6YLAMINE                                           
REMARK 900 RELATED ID: 2WI4   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2BUG   RELATED DB: PDB                                   
REMARK 900  SOLUTION STRUCTURE OF THE TPR DOMAIN FROM PROTEIN                   
REMARK 900  PHOSPHATASE 5 IN COMPLEX WITH HSP90 DERIVED PEPTIDE                 
REMARK 900 RELATED ID: 2UWD   RELATED DB: PDB                                   
REMARK 900  INHIBITION OF THE HSP90 MOLECULAR CHAPERONE IN VITRO                
REMARK 900  AND IN VIVO BY NOVEL, SYNTHETIC, POTENT RESORCINYLIC                
REMARK 900  PYRAZOLE, ISOXAZOLE AMIDE ANALOGS                                   
REMARK 900 RELATED ID: 2YE7   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2YEB   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2WI7   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2XHX   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND              
REMARK 900 RELATED ID: 2BT0   RELATED DB: PDB                                   
REMARK 900  NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR            
REMARK 900   CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED                 
REMARK 900  DESIGN                                                              
REMARK 900 RELATED ID: 2YEJ   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 1YER   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "CLOSED"                   
REMARK 900  CONFORMATION                                                        
REMARK 900 RELATED ID: 2YEC   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2XDU   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 1UYG   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-                  
REMARK 900  FLUORO-9H-PURIN-6-YLAMINE                                           
REMARK 900 RELATED ID: 2CCU   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4-                               
REMARK 900  METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3-               
REMARK 900  YL)-BENZENE-1,3-DIOL                                                
REMARK 900 RELATED ID: 2XDS   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 2XDX   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 2XK2   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 2XJJ   RELATED DB: PDB                                   
REMARK 900  STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND               
REMARK 900 RELATED ID: 1UYD   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2-CHLORO-3,4,5                    
REMARK 900  -TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE                              
REMARK 900 RELATED ID: 2XDL   RELATED DB: PDB                                   
REMARK 900  STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND              
REMARK 900 RELATED ID: 2WI2   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2YEE   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 1UY6   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4,5-TRIMETHOXY                  
REMARK 900  -BENZYL)-9H-PURIN-6-YLAMINE                                         
REMARK 900 RELATED ID: 2YE2   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2VCJ   RELATED DB: PDB                                   
REMARK 900  4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS:                    
REMARK 900  POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER            
REMARK 900 RELATED ID: 1YC4   RELATED DB: PDB                                   
REMARK 900  CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED                     
REMARK 900  WITHDIHYDROXYPHENYLPYRAZOLES                                        
REMARK 900 RELATED ID: 2YE9   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2C2L   RELATED DB: PDB                                   
REMARK 900  CRYSTAL STRUCTURE OF THE CHIP U-BOX E3 UBIQUITIN                    
REMARK 900  LIGASE                                                              
REMARK 900 RELATED ID: 1UYK   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-                       
REMARK 900  YLMETHYL-9-BUTYL-2-FLUORO-9H-PURIN-6-YLAMINE                        
REMARK 900 RELATED ID: 2CCT   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90 WITH 5-(5-CHLORO-2,4-DIHYDROXY-PHENYL)-                 
REMARK 900  4-PIPERAZIN-1-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID                      
REMARK 900  ETHYLAMIDE                                                          
REMARK 900 RELATED ID: 2YK2   RELATED DB: PDB                                   
REMARK 900  TRICYCLIC SERIES OF HSP90 INHIBITORS                                
REMARK 900 RELATED ID: 2WI6   RELATED DB: PDB                                   
REMARK 900  ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE            
REMARK 900   HSP90 CHAPERONE                                                    
REMARK 900 RELATED ID: 2YEA   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 1YC1   RELATED DB: PDB                                   
REMARK 900  CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED                    
REMARK 900  WITHDIHYDROXYPHENYLPYRAZOLES                                        
REMARK 900 RELATED ID: 2YE6   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2YED   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 1UYC   RELATED DB: PDB                                   
REMARK 900  HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-                    
REMARK 900  BENZYL)-9H-PURIN-6-YLAMINE                                          
REMARK 900 RELATED ID: 1YET   RELATED DB: PDB                                   
REMARK 900  GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING                
REMARK 900  DOMAIN                                                              
REMARK 900 RELATED ID: 2YJX   RELATED DB: PDB                                   
REMARK 900  TRICYCLIC SERIES OF HSP90 INHIBITORS                                
REMARK 900 RELATED ID: 2JJC   RELATED DB: PDB                                   
REMARK 900  HSP90 ALPHA ATPASE DOMAIN WITH BOUND SMALL MOLECULE                 
REMARK 900  FRAGMENT                                                            
REMARK 900 RELATED ID: 2YE8   RELATED DB: PDB                                   
REMARK 900  HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL                
REMARK 900  SCREENING                                                           
REMARK 900 RELATED ID: 2YKE   RELATED DB: PDB                                   
REMARK 900  TRICYCLIC SERIES OF HSP90 INHIBITORS                                
REMARK 900 RELATED ID: 2YKC   RELATED DB: PDB                                   
REMARK 900  TRICYCLIC SERIES OF HSP90 INHIBITORS                                
DBREF  2YK9 A   18   223  UNP    P07900   HS90A_HUMAN     18    223             
SEQADV 2YK9 GLY A   15  UNP  P07900              EXPRESSION TAG                 
SEQADV 2YK9 HIS A   16  UNP  P07900              EXPRESSION TAG                 
SEQADV 2YK9 MET A   17  UNP  P07900              EXPRESSION TAG                 
SEQRES   1 A  209  GLY HIS MET GLU THR PHE ALA PHE GLN ALA GLU ILE ALA          
SEQRES   2 A  209  GLN LEU MET SER LEU ILE ILE ASN THR PHE TYR SER ASN          
SEQRES   3 A  209  LYS GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER          
SEQRES   4 A  209  ASP ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP          
SEQRES   5 A  209  PRO SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN          
SEQRES   6 A  209  LEU ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL          
SEQRES   7 A  209  ASP THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN          
SEQRES   8 A  209  ASN LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE          
SEQRES   9 A  209  MET GLU ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE          
SEQRES  10 A  209  GLY GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL          
SEQRES  11 A  209  ALA GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP          
SEQRES  12 A  209  GLU GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE          
SEQRES  13 A  209  THR VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY          
SEQRES  14 A  209  THR LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU          
SEQRES  15 A  209  TYR LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS          
SEQRES  16 A  209  HIS SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL          
SEQRES  17 A  209  GLU                                                          
HET    YK9  A1224      23                                                       
HETNAM     YK9 4-(1H-IMIDAZO[4,5-C]PYRIDIN-2-YL)FLUOREN-9-                      
HETNAM   2 YK9  ONE                                                             
FORMUL   2  YK9    C19 H11 N3 O                                                 
FORMUL   3  HOH   *314(H2 O)                                                    
HELIX    1   1 GLN A   23  THR A   36  1                                  14    
HELIX    2   2 GLU A   42  ASP A   66  1                                  25    
HELIX    3   3 PRO A   67  ASP A   71  5                                   5    
HELIX    4   4 THR A   99  ASN A  105  1                                   7    
HELIX    5   5 ASN A  105  ALA A  124  1                                  20    
HELIX    6   6 ASP A  127  GLY A  135  5                                   9    
HELIX    7   7 VAL A  136  LEU A  143  5                                   8    
HELIX    8   8 GLU A  192  LEU A  198  5                                   7    
HELIX    9   9 GLU A  199  SER A  211  1                                  13    
SHEET    1  AA 8 GLU A  18  ALA A  21  0                                        
SHEET    2  AA 8 SER A 169  THR A 174 -1  O  PHE A 170   N  PHE A  20           
SHEET    3  AA 8 TYR A 160  SER A 164 -1  O  ALA A 161   N  ARG A 173           
SHEET    4  AA 8 ALA A 145  LYS A 153 -1  O  VAL A 148   N  SER A 164           
SHEET    5  AA 8 GLY A 183  LEU A 190 -1  O  GLY A 183   N  LYS A 153           
SHEET    6  AA 8 THR A  88  ASP A  93 -1  O  LEU A  89   N  LEU A 188           
SHEET    7  AA 8 ILE A  78  ASN A  83 -1  O  ASN A  79   N  VAL A  92           
SHEET    8  AA 8 ILE A 218  LEU A 220  1  O  THR A 219   N  LEU A  80           
SITE     1 AC1 13 ILE A  26  LEU A 103  ILE A 104  LEU A 107                    
SITE     2 AC1 13 GLY A 108  GLY A 135  PHE A 138  TYR A 139                    
SITE     3 AC1 13 TRP A 162  PHE A 170  HOH A2009  HOH A2313                    
SITE     4 AC1 13 HOH A2314                                                     
CRYST1   66.429   90.686   98.734  90.00  90.00  90.00 I 2 2 2       8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.015054  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.011027  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.010128        0.00000